Related coverage linked through entity extraction aliases.
Jul 01, 2026
The UK's £1.6bn national AI strategy targets healthcare breakthroughs from cancer detection to drug discovery. The AI healthcare market is forecast to reach US$696bn by 2034, a 38.5% CAGR.
May 01, 2026
Boston Scientific exceeded Q4 2025 guidance with 12.7% organic revenue growth and over $20 billion in annual sales. The company outlined a 2026 outlook of 10-11% organic growth, while shares fell 17.6% after earnings due to supply-chain issues and EP share losses.
Mar 24, 2026
The AI-driven precision medicine market is projected to grow from $0.7 billion in 2025 to $9.7 billion by 2035 at a 26.8% CAGR. North America dominates with 62-67% market share, while machine learning accounts for 39% of the market. The market is moderately consolidated with the top five players controlling over 64% share.
Mar 03, 2026
Phase III trial of 196 patients shows stereotactic radiation targeting individual tumors significantly improved symptom burden and daily functioning compared with hippocampal-avoidance whole-brain radiation, without compromising survival.
